Phathom Pharmaceuticals – Leading the way to innovative …
Phathom Pharmaceuticals is a biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related …
Download Phantom | Crypto wallet for Solana, Ethereum & more
Download Phantom for Solana, Ethereum, Bitcoin, Base & Sui. Available for Chrome, Brave, Firefox, iOS, or Android.
Phathom Pharmaceuticals, Inc. (PHAT) - Yahoo Finance
Find the latest Phathom Pharmaceuticals, Inc. (PHAT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Does Earnings Beat And Voquezna Expansion Change The Bull …
1 day ago · Recently, Raymond James initiated coverage on Phathom Pharmaceuticals with a Strong Buy rating as the company posted third-quarter 2025 results that exceeded forecasts, …
Phathom Pharmaceuticals, Inc. Company Information - Drugs.com
Jun 12, 2023 · Phathom Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 3 drugs in the United States. Medications listed here may also be marketed under …
PHAT: Phathom Pharmaceuticals Inc Latest Stock Price, Analysis, …
Get real-time Phathom Pharmaceuticals Inc (PHAT) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time …
Phathom Pharmaceuticals stock hits 52-week high at $16.27
3 days ago · Phathom Pharmaceuticals Inc. (PHAT) reached a 52-week high, with its stock price climbing to $16.27. This milestone reflects a significant turnaround for the company, which has …
Phantom: The crypto wallet for everyone
Phantom is your go-to crypto wallet. Buy cryptocurrency. Trade memecoins. Store your assets. Grow your portfolio. Available on Solana, Ethereum, Bitcoin, Base, and Sui.
About Us - Phathom Pharmaceuticals
Committed to improving the lives of patients suffering from acid-related gastrointestinal disorders. Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and …
Why Phathom Pharmaceuticals, Inc.’s (PHAT) Stock Is Up 9.27%
3 days ago · As of Friday, December 12, Phathom Pharmaceuticals, Inc.’s PHAT share price has surged by 9.27%, which has investors questioning if this is right time to sell.